Abstract:Introduction: Advanced cutaneous melanoma is a skin cancer characterized by a poor prognosis and high metastatic potential. During metastatic spread, melanoma cells often undergo dedifferentiation toward an invasive phenotype, resulting in reduced expression of microphthalmia-associated transcription factor (MITF)-dependent melanoma antigens and facilitating immune escape. Tumor Necrosis Factor (TNF) is known to be a key factor in melanoma dedifferentiation. Interestingly, accumulating evidence suggests that TNF may play a role in melanoma progression and resistance to immunotherapies. Additionally, TNF has been identified as a potent regulator of sphingolipid metabolism, which could contribute to melanoma aggressiveness and the process of melanoma dedifferentiation. Methods: We conducted RNA sequencing and mass spectrometry analyses to investigate TNF-induced dedifferentiation in two melanoma cell lines. In vitro experiments were performed to manipulate sphingolipid metabolism using genetic or pharmacologic alterations in combination with TNF treatment, aiming to elucidate the potential involvement of this metabolism in TNF-induced dedifferentiation. Lastly, to evaluate the clinical significance of our findings, we performed unsupervised analysis of plasma sphingolipid levels in 48 patients receiving treatment with immune checkpoint inhibitors, either alone or in combination with anti-TNF therapy. Results: Herein, we demonstrate that TNF-induced melanoma cell dedifferentiation is associated with a global modulation of sphingolipid metabolism. Specifically, TNF decreases the expression and activity of acid ceramidase (AC), encoded by the ASAH1 gene, while increasing the expression of glucosylceramide synthase (GCS), encoded by the UGCG gene. Remarkably, knockdown of AC alone via RNA interference is enough to induce melanoma cell dedifferentiation. Furthermore, treatment with Eliglustat, a GCS inhibitor, inhibits TNF-induced melanoma cell dedifferentiation. Lastly, analysis of plasma samples from patients treated with immune checkpoint inhibitors, with or without anti-TNF therapy, revealed significant predictive sphingolipids. Notably, the top 8 predictive sphingolipids, including glycosphingolipids, were associated with a poor response to immunotherapy. Discussion: Our study highlights that ceramide metabolism alterations are causally involved in TNF-induced melanoma cell dedifferentiation and suggests that the evolution of specific ceramide metabolites in plasma may be considered as predictive biomarkers of resistance to immunotherapy.

Ceramide Reproduces Late Appearance of Oxidative Stress during TNF-Mediated Cell Death in L929 Cells

Influence of inhibitor of signal transduction on the cell apoptosis induced by TNF β

Effects of Antioxidants and Nitric Oxide on TNF-α-induced Adhesion Molecule Expression and NF-κB Activation in Human Dermal Microvascular Endothelial Cells

Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate

TUMOUR NECROSIS FACTOR-INDUCED NECROSIS VERSUS ANTI-Fas-INDUCED APOPTOSIS IN L929 CELLS

An Early and Robust Activation of Caspases Heads Cells for a Regulated Form of Necrotic-like Cell Death

Palmitoyl-ceramide accumulation with necrotic cell death in A549 cells, followed by a steep increase in sphinganine content

Oxidatively Truncated Phospholipids Are Required Agents of Tumor Necrosis Factor Α (Tnfα)-Induced Apoptosis

Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells

Necroptosis Occurs in Osteoblasts During Tumor Necrosis Factor-Α Stimulation and Caspase-8 Inhibition

Ceramide induces the apoptosis of non‐small cell lung cancer cells through the Txnip/Trx1 complex

Ceramide metabolism alterations contribute to Tumor Necrosis Factor-induced melanoma dedifferentiation and predict resistance to immune checkpoint inhibitors in advanced melanoma patients

Endoplasmic reticulum stress induces ligand-independent TNFR1-mediated necroptosis in L929 cells

Ceramide and ceramide 1-phosphate are negative regulators of TNF-α production induced by lipopolysaccharide

Ceramide kinase regulates TNF-α-induced immune responses in human monocytic cells

Membranes as sensitive targets in thymocyte apoptosis

Aging-dependent Mitochondrial Dysfunction Mediated by Ceramide Signaling Inhibits Antitumor T Cell Response

Autophagy Inhibits C2-ceramide-mediated Cell Death by Decreasing the Reactive Oxygen Species Levels in SH-SY5Y Cells

Study on tumor necrosis factor-α induced eryptosis

Ceramide Does Not Act As a General Second Messenger for Ultraviolet-Induced Apoptosis

Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling